Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.36 is 36% below its 5-year average of 5.26, near the low end of its 5-year range (2.16–9.44).
As of the fiscal period ended Tuesday, June 30, 2026. 21.82% above its 12-month average of 2.76.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.36.
CURRENT RATIO
3.36
CURRENT RATIO AVG TTM
2.76
CURRENT RATIO AVG 3Y
3.81
CURRENT RATIO AVG 5Y
5.26
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+21.82%
CURRENT VS 3Y AVG
-11.81%
CURRENT VS 5Y AVG
-36.07%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.69
median of 825 covered companies
CURRENT VS SECTOR MEDIAN
-8.89%
vs the sector median at left
Foghorn Therapeutics Inc.
Market Cap
$111.56M
Current Ratio
3.36
TTM Avg
2.76
3Y Avg
3.81
5Y Avg
5.26
Market Cap
$112.70M
Current Ratio
12.63
TTM Avg
12.83
3Y Avg
15.22
5Y Avg
15.22
Market Cap
$112.21M
Current Ratio
2.00
TTM Avg
1.45
3Y Avg
1.62
5Y Avg
1.71
Market Cap
$109.49M
Current Ratio
5.68
TTM Avg
5.13
3Y Avg
4.85
5Y Avg
5.20
Market Cap
$108.78M
Current Ratio
0.96
TTM Avg
1.08
3Y Avg
1.26
5Y Avg
1.56
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Foghorn Therapeutics Inc. (FHTX) | $111.56M | 3.36 | 2.76 | 3.81 | 5.26 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $112.70M | 12.63 | 12.83 | 15.22 | 15.22 |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $112.21M | 2.00 | 1.45 | 1.62 | 1.71 |
| BGM Group Ltd. (BGM)vs › | $111.90M | 1.25 | 2.31 | 3.27 | 2.89 |
| Lucid Diagnostics Inc. (LUCD)vs › | $112.77M | 1.33 | 1.19 | 1.50 | 3.26 |
| MaxCyte, Inc. (MXCT)vs › | $113.01M | 12.26 | 9.59 | 11.55 | 11.23 |
| Apyx Medical Corporation (APYX)vs › | $109.49M | 5.68 | 5.13 | 4.85 | 5.20 |
| Genelux Corporation (GNLX)vs › | $113.89M | 2.39 | 3.50 | 2.69 | 1.97 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $108.78M | 0.96 | 1.08 | 1.26 | 1.56 |
| Caribou Biosciences, Inc. (CRBU)vs › | $115.05M | 6.49 | 6.44 | 8.52 | 8.53 |
Current Ratio
3.36
Quick Ratio
3.36
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.36 |
| 2026-03-31 | 2.92 |
| 2025-12-31 | 2.73 |
| 2025-09-30 | 2.16 |
| 2025-06-30 | 2.62 |
| 2025-03-31 | 3.16 |
| 2024-12-31 | 3.73 |
| 2024-09-30 | 4.77 |
| 2024-06-30 | 5.69 |
| 2024-03-31 | 4.06 |
| 2023-12-31 | 4.11 |
| 2023-09-30 | 5.10 |
| 2023-06-30 | 5.13 |
| 2023-03-31 | 5.75 |
| 2022-12-31 | 6.37 |
| 2022-09-30 | 6.84 |
| 2022-06-30 | 8.34 |
| 2022-03-31 | 8.91 |
| 2021-12-31 | 9.44 |
| 2021-09-30 | 6.42 |
| 2021-06-30 | 8.81 |
| 2021-03-31 | 10.12 |
| 2020-12-31 | 10.12 |
| 2020-09-30 | 3.65 |
| 2020-06-30 | 2.46 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 1.33 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
